According to Arcadia Biosciences's latest financial reports the company has $12.7 M in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $20.9 M | -33% |
2021-12-31 | $31.19 M | 9.26% |
2020-12-31 | $28.55 M | 242.93% |
2019-12-31 | $8.32 M | -35.03% |
2018-12-31 | $12.81 M | 60.05% |
2017-12-31 | $8 M | -63.93% |
2016-12-31 | $22.19 M | -44.82% |
2015-12-31 | $40.22 M | -147.45% |
2014-12-31 | $-84.77 M | 390.06% |
2013-12-31 | $-17.3 M | 204.31% |
2012-12-31 | $-5.69 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Codexis
CDXS | $86.61 M | 581.85% | ๐บ๐ธ USA |
ScottsMiracle-Gro SMG | -$0.39 B | -3,133.93% | ๐บ๐ธ USA |
American Vanguard AVD | $0.37 B | 2,812.78% | ๐บ๐ธ USA |